<DOC>
	<DOCNO>NCT02299310</DOCNO>
	<brief_summary>The purpose study compare effect valsartan perindopril HOMA-IR Index patient chronic kidney disease .</brief_summary>
	<brief_title>Effect Valsartan v Perindopril HOMA-IR Index Patients With Chronic Kidney Disease</brief_title>
	<detailed_description>eligiable volunteer administrate single-dose period I II ( crossover ) Valsartan ( 80mg ) Perindopril ( 4mg ) . Every time medication , HOMA-IR index parameter safety Valsartan ( 80mg ) Perindopril ( 4mg ) perform use blood sample conduct test ( vital sign , physical exam , ECG , laboratory test , etc . ) respectively .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Perindopril</mesh_term>
	<criteria>Clinical diagnosis chronic kidney disease Serum creatinine:1~3mg/dl Diabetes Patients treated corticosteroid immunosuppressant BMI &gt; 30kg/m2 SP &gt; 180mmHg , DP &gt; 110mmHg Patients serious medical problem require specific medical treatment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Chronic kidney disease , Anti-hypertensive drug</keyword>
</DOC>